Immunoprofile of adenosquamous carcinoma in gastric cancer

Cheng-Han Wu(The University of Texas MD Anderson Cancer Center), Ming‐Huang Chen(National Yang Ming Chiao Tung University)

Journal of the Chinese Medical Association

March 29, 2023

10.1097/jcma.0000000000000922

Cited by 20

Related Papers

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2023|1k

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

|The Lancet. Gastroenterology & hepatology|2024|245

Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients

|Oncotarget|2017|20

Sjögren’s Syndrome Antigen B Acts as an Endogenous Danger Molecule to Induce Interleukin-8 Gene Expression in Polymorphonuclear Neutrophils

|PLoS ONE|2015|8